ABTA Featured Clinical Trial

by | Jun 12, 2024 | GBM

📣 ReSPECT-GBM Clinical Trial is now a @the_abta Featured Clinical Study Check it out here: https://bit.ly/45iB7WE The American Brain Tumor Association’s (ABTA) Featured Clinical Trial Program is part of their ongoing efforts to educate and support patients with brain...

Musella GBM Patient Webinar

by | May 6, 2024 | GBM

➡️ GLIOBLASTOMA PATIENT WEBINAR ⬅️ Join us as the @MusellaFoundation hosts Dr. Andrew Brenner and Dr. Marc Hedrick in a discussion about the ReSPECT-GBM Phase 2 Clinical Trial for Recurrent Glioblastoma. The webinar will take place May 20 2pm EST with a recording to...

Plus Approach

by | Apr 3, 2024 | GBM

Plus Therapeutics’ novel approach to treating Glioblastoma overcomes the limitations of all three currently employed treatment modalities. Leveraging established, targeted delivery techniques, we seek to inject high doses of radiation directly into or near a...